Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00974623 · ClinicalTrials.gov registry record
Bone Graft Materials Observational Registry
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- 329
- Enrollment target
NCT00974623: Clinical Trial study, sponsored by Baxter Healthcare Corporation.
NCT00974623 is a clinical trial that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 329 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00974623 was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- 329 participants
- Enrollment target
Study Summary
A multi-center, prospective, observational patient registry to collect information on the clinical outcomes and "real world" use of approved and commercially available bone graft substitutes, autograft and allograft.
Interventions
- DEVICE Bone graft substitute, autograft or allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-11 |
Why NCT00974623 stopped before completion
NCT00974623 is an observational study that tracks outcomes without assigning an intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Bone graft substitute, autograft or allograft is the first listed.
NCT00974623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00974623 about?
NCT00974623 is a clinical study titled "Bone Graft Materials Observational Registry". A multi-center, prospective, observational patient registry to collect information on the clinical outcomes and "real world" use of approved and commercially available bone graft substitutes, autograft and allograft.
What is the current status of trial NCT00974623?
This trial is currently terminated. The enrollment target is 329 participants. The study started on 2009-09. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00974623?
The interventions under investigation include: Bone graft substitute, autograft or allograft (DEVICE).
Who is sponsoring clinical trial NCT00974623?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06036446 · 329 participants · NA
LATe Cerclage in High-risk Pregnancies (LATCH)
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia